Invention Grant
- Patent Title: Treatment of amyotrophic lateral sclerosis (ALS)
-
Application No.: US16756586Application Date: 2018-10-16
-
Publication No.: US11434502B2Publication Date: 2022-09-06
- Inventor: Dinah Wen-Yee Sah , Qingmin Chen , Holger Patzke , Jinzhao Hou
- Applicant: VOYAGER THERAPEUTICS, INC.
- Applicant Address: US MA Cambridge
- Assignee: VOYAGER THERAPEUTICS, INC.
- Current Assignee: VOYAGER THERAPEUTICS, INC.
- Current Assignee Address: US MA Cambridge
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Cynthia L. Kanik
- International Application: PCT/US2018/055999 WO 20181016
- International Announcement: WO2019/079240 WO 20190425
- Main IPC: C07H21/02
- IPC: C07H21/02 ; C07H21/04 ; C12N15/86 ; A61P25/28 ; A61K31/713 ; C12N15/113
Abstract:
The present invention relates to AAVs encoding a SOD1 targeting polynucleotide which may be used to treat amyotrophic lateral sclerosis (ALS) and/or canine degenerative myelopathy (DM).
Public/Granted literature
- US20200239912A1 TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS) Public/Granted day:2020-07-30
Information query
